BioSeeker Group AB Research Reports

Title	Published	Price
Nordic Life Science Industry Guide 2008 By: BioSeeker Group AB The "Nordic Life Science Industry Guide 2008" is a unique CD-ROM product that contains a searchable directory of 1,500 life science companies in Scandinavia (Denmark, Norway, Finland and Sweden). BioSeeker has divided the industry into \| more...	3/18/2008	$299.00
HCV R&D and Business Development Database By: BioSeeker Group AB This unique CD-ROM database product is one of the most comprehensive and up to date information sources on chronic hepatitis C virus R&D and business development. The database contains extensive corporate, R&D, and business collaboration \| more...	6/22/2004	$375.00
Antifungals: 2004 and Beyond By: BioSeeker Group AB Executive Summary The market for antifungal agents continues to grow. According to an article in BioBN, "the worldwide market for treatment of invasive fungal infections is estimated to reach $2.4 billion in 2003 and \| more...	10/19/2004	$443.00
Promising Drug Discovery Tools in Antifungal & Status on Emerging Novel Targets By: BioSeeker Group AB The antifungal market is steadily growing and fungal infections is today the third most common hospital-acquired infection. The global market is estimated to be worth more than $3 billion USD. Fungal infections have emerged as \| more...	8/24/2004	$443.00
Market Development in Anti-virals:What is Next? By: BioSeeker Group AB There are huge unmet medical needs in viral infections. Any virus can become multi-resistant and a consequence of this is the constant need for new improved pharmaceuticals. The total anti-viral market is progressing well beyond \| more...	8/24/2004	$443.00
The Handbook on Alliances & Deals in Biotech Business By: BioSeeker Group AB "The only way to win in this business is to have alliances, both for small companies and large ones." (Executive manager of a large biotech company). The number of new alliances has increased ten-fold \| more...	5/4/2004	$443.00
Guide to Venture Capital in European Biopharma By: BioSeeker Group AB Executive Summary If you are managing a biopharma company, raising venture capital can be absolutely critical for the success of your company. The fund raising process should therefore be planned and carried out \| more...	9/14/2004	$443.00
Swedish Biopharma Profiles 2002 By: BioSeeker Group AB The Swedish biopharma industry has experienced a dramatic growth from 25 companies in 1996 to 52 companies in 2002. In this informative profile report, BioSeeker Groups presents all 52 biopharma companies with either research and \| more...	9/25/2002	$471.15
R&D in Swedish Biopharma Companies 2002 By: BioSeeker Group AB The Swedish biopharma industry is founded on a very strong scientific base. This is reflected in the technology platforms that are readily identified among many of the companies. This report focuses on the R&D performed \| more...	9/25/2002	$492.75
Pan-European Investors in Biotechnology By: BioSeeker Group AB This report brings you up to date with 526 pan European investors in biotechnology. We list their financial strength and how they prefer to invest. Target key VC principals for each firm via or detailed \| more... Search inside this report	2/1/2002	$538.65
The Next Generation of Antifungals: Triazoles vs. Peptides By: BioSeeker Group AB According to the Antifungal Work Group at NIH there is a "critical need for the development of antifungal agents" (Draft report of the Antifungal Working Group). "There is not a single rapidly fungicidal, non-toxic drug \| more... Search inside this report	10/8/2002	$668.25
European Biotech Industry Guide 2007, 5th Ed. By: BioSeeker Group AB Executive Summary This exciting intelligence CD-ROM on European biotech industry has become better, stronger and more intelligent in its 5th Edition. The 5th Edition of European Biotech Industry Guide has not only been updated \| more...	2/7/2007	$671.00
World Guide to Bionanotechnology Industry and its Progression, 2nd ED By: BioSeeker Group AB Executive Summary Nanotechnology, or the science of the small, holds enormous promise across all industries, not at least in life science. Since mid 90th there has been increasing intersection of two important scientific fields, nanotechnology \| more...	10/24/2005	$699.00
Future HCV Drug Discovery Technologies By: BioSeeker Group AB Executive Summary The main hindrance to drug development for hepatitis C has been the lack of a small animal model or productive tissue culture system for assessing drug action. This problem has been \| more...	11/25/2002	$735.75
Competitive Outlook on HCV: What to Know & Expect in R&D and Business Development By: BioSeeker Group AB The competitive business environment for the pharmaceutical market of chronic hepatitis C virus (HCV) infection is fierce and changing. The entry of Hoffmann-La Roche into this $3 billion market, previously dominated by Schering-Plough, has certainly \| more...	6/22/2004	$749.00
Ion Channel Drug Discovery - Therapeutic Opportunities & Technology Progress By: BioSeeker Group AB Increased knowledge of novel targets in combination with a strong progress in drug discovery technologies has strongly contributed to the fast development in ion channel drug discovery that we are witnessing today. This progress \| more...	5/11/2004	$749.00
European Biotech Industry Guide 2006, 4th Ed. By: BioSeeker Group AB Executive Summary This exciting intelligence CD-ROM on European biotech industry has become better, stronger and more intelligent in its 4th Edition. The 4th d Edition of "European Biotech Industry Guide" has not only been updated \| more...	2/13/2006	$791.00
Finnish Biotech Industry Guide 2004 By: BioSeeker Group AB The "Finnish Biotech Industry Guide 2004" is a unique CD product that contains a searchable database of more than 179 biotech companies. BioSeeker has divided the Finnish biotech industry into 16 different industry segments, such \| more...	1/20/2004	$808.65
Ion Channel Assays as Therapeutic Targets for Multiple Diseases By: BioSeeker Group AB Ion channels play an important role in numerous cell types and occur as large families of related genes with cell-specific expression patterns. Considering the publication of the human genome and the progress in transcription profiling \| more... Search inside this report	11/7/2002	$857.25
Superficial Bladder Cancer - Current Mangement and Future Trends By: BioSeeker Group AB Executive Summary Superficial bladder cancers (SBC) comprise tumours with low aggressiveness but a high recurrence rate as well as lesions with a high risk of progression. All SBC are amenable to intravesical therapy and treatment \| more...	11/1/2005	$903.00
Fierce Competition for a Shrinking HCV Market By: BioSeeker Group AB Hepatitis C virus (HCV) has already caused a global epidemic, but the worst may yet be to come. According to the CDC nearly 4 million people are or have been infected with HCV in the \| more... Buy by the section \| Search inside this report	10/21/2002	$911.25
Ion Channels as Therapeutic Targets for Multiple Diseases By: BioSeeker Group AB Executive Summary Ion channels play an important role in numerous cell types and occur as large families of related genes with cell-specific expression patterns. Considering the publication of the human genome and the \| more...	11/7/2002	$924.75
New Targets and Drug Discovery Platforms in Antifungal R&D By: BioSeeker Group AB Executive Summary According to the Antifungal Work Group at NIH there is a “critical need for the development of antifungal agents“. The urgency stems from the therapeutic limitations of the present antifungal compounds \| more...	11/25/2002	$1,005.75
Analytical Tool: Competitive Outlook on HCV By: BioSeeker Group AB BioSeeker Group's "Analytical Tool: Competitive Outlook on HCV", represents a powerful product combination of the independent and unbiased analytical report Competitive Outlook on HCV: What to Know & Expect in R&D and Business Development and \| more...	7/7/2004	$1,125.00
Analytical Tool: Competitive Outlook on HCV By: BioSeeker Group AB BioSeeker Group's "Analytical Tool: Competitive Outlook on HCV", represents a powerful product combination of the independent and unbiased analytical report Competitive Outlook on HCV: What to Know & Expect in R&D and Business Development and \| more...	6/22/2004	$1,125.00
Title	Published	Price

< prev 1 2 3 4 5 6 7 next >

Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: customerservice@marketresearch.com
Copyright © 1999-2009, All Rights Reserved, MarketResearch.com
11/23/2009 - 3